NELOFAR BARLAS: Open Payments
NPI 1750704482 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 4 payments from 4 companies in 2025. Trend: 2023 $207 · 2024 $106 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 1 | $192 |
| Esperion Therapeutics, Inc. | 1 | $131 |
| Novartis Pharmaceuticals Corporation | 1 | $125 |
| Novo Nordisk Inc | 1 | $117 |
Products named: FFRct, NEXLETOL, LEQVIO.
Industry payments across CA — which companies pay providers there.
